{
  "ticker": "PME.AX",
  "company": "Pro Medicus",
  "sector": "Healthcare IT",
  "market_cap": "14.1B",
  "hypotheses": {
    "D1": {
      "label": "US Expansion Accelerates",
      "description": "Pro Medicus executes on growth strategy; earnings accelerate",
      "plain_english": "Pro Medicus continues winning major US health system contracts, growing from ~10% to 25%+ market share over the next 5 years. Cloud-native architecture creates structural cost advantage competitors cannot replicate.",
      "what_to_watch": "Next earnings result and forward guidance.",
      "upside": "Material re-rating if execution surprises to the upside.",
      "risk_plain": "If growth disappoints, this narrative weakens.",
      "survival_score": 0.6,
      "status": "MODERATE",
      "weighted_inconsistency": 3,
      "last_updated": "2026-02-16T06:49:06.276Z"
    },
    "D2": {
      "label": "Valuation Mean-Reversion",
      "description": "Pro Medicus delivers steady-state results; valuation holds",
      "plain_english": "The 163x P/E contracts to a more conventional 50-80x as growth decelerates or market sentiment shifts. Even extraordinary business quality has a price.",
      "what_to_watch": "Margin trends and competitive dynamics.",
      "upside": null,
      "risk_plain": "If the base case is already priced in, limited upside from here.",
      "survival_score": 0.35,
      "status": "MODERATE",
      "weighted_inconsistency": 2,
      "last_updated": "2026-02-16T06:49:06.276Z"
    },
    "D3": {
      "label": "Competitive Disruption",
      "description": "Pro Medicus faces headwinds; earnings or multiples compress",
      "plain_english": "A competitor (existing or new entrant) develops a platform that matches Visage 7's cloud-native architecture, eroding Pro Medicus's structural advantage.",
      "what_to_watch": "Cost pressures, competitive threats, or macro headwinds.",
      "upside": null,
      "risk_plain": "Material downside if multiple risks crystallise simultaneously.",
      "survival_score": 0.2,
      "status": "LOW",
      "weighted_inconsistency": 4,
      "last_updated": "2026-02-16T06:49:06.276Z"
    },
    "D4": {
      "label": "AI Amplifies the Moat",
      "description": "A structural shift changes the investment case for Pro Medicus",
      "plain_english": "Pro Medicus becomes the platform on which AI radiology tools run, deepening stickiness and expanding per-study economics. Platform companies historically capture more value than point-solution vendors.",
      "what_to_watch": "Industry disruption signals and regulatory changes.",
      "upside": "See research report for upside scenario detail.",
      "risk_plain": "If disruption materialises, prior assumptions become invalid.",
      "survival_score": 0.5,
      "status": "LOW",
      "weighted_inconsistency": 5,
      "last_updated": "2026-02-16T06:49:06.276Z"
    }
  },
  "dominant": "D1",
  "confidence": "LOW",
  "alert_state": "NORMAL",
  "current_price": 126.51,
  "big_picture": "The most extraordinary business on the ASX: Visage 7 generates 77% EBITDA margins with 132 employees (A$1.6M rev/head). Zero debt, A$211M cash, A$520M in new FY25 contracts including Trinity Health (A$330M) and UCHealth (A$170M). Revenue grew 32%, NPAT up 39%. US market share only ~10%. Morningstar's A$36 fair value is analytically questionable for a platform business with this quality of economics.",
  "last_flip": null,
  "narrative_history": [],
  "evidence_items": [],
  "price_signals": [],
  "editorial_override": null,
  "price_history": [],
  "weighting": null,
  "gics_sub_industry": "Health Care Equipment",
  "narrative_model": "HEALTHCARE_DEVICES_MEDTECH",
  "narrative_weights": {
    "macro": 0.03,
    "sector": 0.02,
    "tech": 0.1,
    "company": 0.85
  },
  "commodity_overlay": null,
  "priceHistory": [
    123.19,
    127.35,
    129.16,
    125.14,
    127.27,
    126.51
  ],
  "freshness": {
    "pricePctChange": -0.6,
    "urgency": 0,
    "status": "OK",
    "badge": "ok"
  },
  "last_price_update": "2026-02-20T06:11:55.433Z",
  "last_research_update": "2026-02-22T21:50:16.817Z",
  "three_layer_signal": {
    "date": "2026-02-20",
    "macro_signal": 12,
    "sector_signal": 0,
    "tech_signal": 0,
    "idio_signal": 24,
    "company_signal": 24,
    "overall_sentiment": 21,
    "sentiment_label": "UPSIDE",
    "macro_contribution": 0,
    "sector_contribution": 0,
    "tech_contribution": 0,
    "company_contribution": 20,
    "idio_contribution": 20,
    "external_signal": 0,
    "sector_detail": {
      "signal": 0,
      "detail": "company_dominant"
    },
    "idio_detail": {
      "signal": 24,
      "detail": "dominance_sqrt",
      "D1": "D1",
      "D1_score": 37,
      "D1_sentiment": "BULLISH",
      "D2": "D4",
      "D2_score": 30,
      "lead": 7,
      "raw_signal": 24.4
    }
  },
  "risk_skew": "UPSIDE"
}